| Name |
|---|
LARGE Genelike-glycosyltransferase This gene encodes a member of the N-acetylglucosaminyltransferase gene family. It encodes a glycosyltransferase which participates in glycosylation of alpha-dystroglycan, and may carry out the synthesis of glycoprotein and glycosphingolipid sugar chains. It may also be involved in the addition of a repeated disaccharide unit. The protein encoded by this gene is the glycotransferase that adds the final xylose and glucuronic acid to alpha-dystroglycan and thereby allows alpha-dystroglycan to bind ligands including laminin 211 and neurexin. Mutations in this gene cause several forms of congenital muscular dystrophy characterized by cognitive disability and abnormal glycosylation of alpha-dystroglycan. Alternative splicing of this gene results in multiple transcript variants that encode the same protein. [provided by RefSeq, May 2018] |
LARGE-AS1 GeneLARGE antisense RNA 1 |
LARGE-IT1 GeneLARGE intronic transcript 1 |
DLGAP2 Genediscs, large (Drosophila) homolog-associated protein 2 The product of this gene is a membrane-associated protein that may play a role in synapse organization and signalling in neuronal cells. This gene is biallelically expressed in the brain, however, only the paternal allele is expressed in the testis (PMID:18055845). Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jun 2014] |
DLGAP3 Genediscs, large (Drosophila) homolog-associated protein 3 Predicted to enable PDZ domain binding activity; molecular adaptor activity; and scaffold protein binding activity. Predicted to be involved in modulation of chemical synaptic transmission and protein-containing complex assembly. Predicted to be located in plasma membrane. Predicted to be active in several cellular components, including cholinergic synapse; glutamatergic synapse; and neuromuscular junction. [provided by Alliance of Genome Resources, Mar 2025] |
DLGAP1 Genediscs, large (Drosophila) homolog-associated protein 1 Predicted to enable molecular adaptor activity. Predicted to be a structural constituent of postsynaptic density. Predicted to be involved in several processes, including aggresome assembly; protein localization to synapse; and regulation of proteasomal protein catabolic process. Predicted to be located in plasma membrane. Predicted to be active in glutamatergic synapse and postsynaptic density, intracellular component. [provided by Alliance of Genome Resources, Mar 2025] |
DLGAP4 Genediscs, large (Drosophila) homolog-associated protein 4 The product of this gene is a membrane-associated guanylate kinase found at the postsynaptic density in neuronal cells. It is a signaling molecule that can interact with potassium channels and receptors, as well as other signaling molecules. The protein encoded by this gene can interact with PSD-95 through its guanylate kinase domain and may be involved in clustering PSD-95 in the postsynaptic density region. The encoded protein is one of at least four similar proteins that have been found. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008] |
DLGAP5 Genediscs, large (Drosophila) homolog-associated protein 5 Predicted to enable microtubule binding activity. Predicted to be involved in several processes, including centrosome localization; kinetochore assembly; and mitotic spindle organization. Located in cytosol; nucleus; and spindle. [provided by Alliance of Genome Resources, Mar 2025] |
RPLP2P2 Generibosomal protein, large, P2 pseudogene 2 |
RPLP0P10 Generibosomal protein, large, P0 pseudogene 10 |
LOC390860 Generibosomal protein, large, P0 pseudogene |
RPLP1P12 Generibosomal protein, large, P1 pseudogene 12 |
RPLP1P13 Generibosomal protein, large, P1 pseudogene 13 |
RPLP1P10 Generibosomal protein, large, P1 pseudogene 10 |
RPLP1P11 Generibosomal protein, large, P1 pseudogene 11 |
RPLP0P11 Generibosomal protein, large, P0 pseudogene 11 |
KCNMA1 Genepotassium channel, calcium activated large conductance subfamily M alpha, member 1 This gene encodes the alpha subunit of calcium-activated BK channel. The encoded protein is involved in several physiological processes including smooth muscle contraction, neurotransmitter release and neuronal excitability. Mutations in this gene are associated with a spectrum of neurological disorders including Paroxysmal Nonkinesigenic Dyskinesia 3, Idiopathic Generalized Epilepsy 16 and Liang-Wang syndrome. [provided by RefSeq, Aug 2022] |
LOC101930420 GeneDNA primase large subunit-like |
RPLP1P1 Generibosomal protein, large, P1 pseudogene 1 |
RPLP1P3 Generibosomal protein, large, P1 pseudogene 3 |
RPLP1P4 Generibosomal protein, large, P1 pseudogene 4 |
RPLP1P5 Generibosomal protein, large, P1 pseudogene 5 |
RPLP1P7 Generibosomal protein, large, P1 pseudogene 7 |
RPLP1P8 Generibosomal protein, large, P1 pseudogene 8 |
RPLP1P9 Generibosomal protein, large, P1 pseudogene 9 |
DLG3 Genediscs, large homolog 3 (Drosophila) This gene encodes a member of the membrane-associated guanylate kinase protein family. The encoded protein may play a role in clustering of NMDA receptors at excitatory synapses. It may also negatively regulate cell proliferation through interaction with the C-terminal region of the adenomatosis polyposis coli tumor suppressor protein. Mutations in this gene have been associated with X-linked cognitive disability. Alternatively spliced transcript variants have been described. [provided by RefSeq, Oct 2009] |
DLG2 Genediscs, large homolog 2 (Drosophila) This gene encodes a member of the membrane-associated guanylate kinase (MAGUK) family. The encoded protein forms a heterodimer with a related family member that may interact at postsynaptic sites to form a multimeric scaffold for the clustering of receptors, ion channels, and associated signaling proteins. Multiple transcript variants encoding different isoforms have been found for this gene. Additional transcript variants have been described, but their full-length nature is not known. [provided by RefSeq, Dec 2008] |
DLG5 Genediscs, large homolog 5 (Drosophila) This gene encodes a member of the family of discs large (DLG) homologs, a subset of the membrane-associated guanylate kinase (MAGUK) superfamily. The MAGUK proteins are composed of a catalytically inactive guanylate kinase domain, in addition to PDZ and SH3 domains, and are thought to function as scaffolding molecules at sites of cell-cell contact. The protein encoded by this gene localizes to the plasma membrane and cytoplasm, and interacts with components of adherens junctions and the cytoskeleton. It is proposed to function in the transmission of extracellular signals to the cytoskeleton and in the maintenance of epithelial cell structure. Alternative splice variants have been described but their biological nature has not been determined. [provided by RefSeq, Jul 2008] |
DLG1 Genediscs, large homolog 1 (Drosophila) This gene encodes a multi-domain scaffolding protein that is required for normal development. This protein may have a role in septate junction formation, signal transduction, cell proliferation, synaptogenesis and lymphocyte activation. A multitude of transcript variants deriving from alternative splicing and the use of multiple alternate promoter have been observed, including some splice variants that may be specific to brain and other tissues. An upstream uORF may regulate translation at some splice variants of this gene. [provided by RefSeq, Sep 2018] |
DLG4 Genediscs, large homolog 4 (Drosophila) This gene encodes a member of the membrane-associated guanylate kinase (MAGUK) family. It heteromultimerizes with another MAGUK protein, DLG2, and is recruited into NMDA receptor and potassium channel clusters. These two MAGUK proteins may interact at postsynaptic sites to form a multimeric scaffold for the clustering of receptors, ion channels, and associated signaling proteins. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008] |
LATS2 Genelarge tumor suppressor kinase 2 This gene encodes a serine/threonine protein kinase belonging to the LATS tumor suppressor family. The protein localizes to centrosomes during interphase, and early and late metaphase. It interacts with the centrosomal proteins aurora-A and ajuba and is required for accumulation of gamma-tubulin and spindle formation at the onset of mitosis. It also interacts with a negative regulator of p53 and may function in a positive feedback loop with p53 that responds to cytoskeleton damage. Additionally, it can function as a co-repressor of androgen-responsive gene expression. [provided by RefSeq, Jul 2008] |
LATS1 Genelarge tumor suppressor kinase 1 The protein encoded by this gene is a putative serine/threonine kinase that localizes to the mitotic apparatus and complexes with cell cycle controller CDC2 kinase in early mitosis. The protein is phosphorylated in a cell-cycle dependent manner, with late prophase phosphorylation remaining through metaphase. The N-terminal region of the protein binds CDC2 to form a complex showing reduced H1 histone kinase activity, indicating a role as a negative regulator of CDC2/cyclin A. In addition, the C-terminal kinase domain binds to its own N-terminal region, suggesting potential negative regulation through interference with complex formation via intramolecular binding. Biochemical and genetic data suggest a role as a tumor suppressor. This is supported by studies in knockout mice showing development of soft-tissue sarcomas, ovarian stromal cell tumors and a high sensitivity to carcinogenic treatments. [provided by RefSeq, Apr 2017] |
RPLP0P9 Generibosomal protein, large, P0 pseudogene |
RPLP0P8 Generibosomal protein, large, P0 pseudogene 8 |
RPLP0P1 Generibosomal protein, large, P0 pseudogene 1 |
RPLP0P3 Generibosomal protein, large, P0 pseudogene 3 |
RPLP0P2 Generibosomal protein, large, P0 pseudogene 2 |
RPLP0P5 Generibosomal protein, large, P0 pseudogene 5 |
RPLP0P4 Generibosomal protein, large, P0 pseudogene 4 |
RPLP0P7 Generibosomal protein, large, P0 pseudogene 7 |
RPLP0P6 Generibosomal protein, large, P0 pseudogene 6 Predicted to enable large ribosomal subunit rRNA binding activity. Predicted to be a structural constituent of ribosome. Predicted to be involved in cytoplasmic translation. Predicted to be located in ribosome. Predicted to be part of cytosolic large ribosomal subunit. [provided by Alliance of Genome Resources, Mar 2025] |
RPLP2 Generibosomal protein, large, P2 Ribosomes, the organelles that catalyze protein synthesis, consist of a small 40S subunit and a large 60S subunit. Together these subunits are composed of 4 RNA species and approximately 80 structurally distinct proteins. This gene encodes a ribosomal phosphoprotein that is a component of the 60S subunit. The protein, which is a functional equivalent of the E. coli L7/L12 ribosomal protein, belongs to the L12P family of ribosomal proteins. It plays an important role in the elongation step of protein synthesis. Unlike most ribosomal proteins, which are basic, the encoded protein is acidic. Its C-terminal end is nearly identical to the C-terminal ends of the ribosomal phosphoproteins P0 and P1. The P2 protein can interact with P0 and P1 to form a pentameric complex consisting of P1 and P2 dimers, and a P0 monomer. The protein is located in the cytoplasm. As is typical for genes encoding ribosomal proteins, there are multiple processed pseudogenes of this gene dispersed through the genome. [provided by RefSeq, Jul 2008] |
RPLP1 Generibosomal protein, large, P1 Ribosomes, the organelles that catalyze protein synthesis, consist of a small 40S subunit and a large 60S subunit. Together these subunits are composed of 4 RNA species and approximately 80 structurally distinct proteins. This gene encodes a ribosomal phosphoprotein that is a component of the 60S subunit. The protein, which is a functional equivalent of the E. coli L7/L12 ribosomal protein, belongs to the L12P family of ribosomal proteins. It plays an important role in the elongation step of protein synthesis. Unlike most ribosomal proteins, which are basic, the encoded protein is acidic. Its C-terminal end is nearly identical to the C-terminal ends of the ribosomal phosphoproteins P0 and P2. The P1 protein can interact with P0 and P2 to form a pentameric complex consisting of P1 and P2 dimers, and a P0 monomer. The protein is located in the cytoplasm. Two alternatively spliced transcript variants that encode different proteins have been observed. As is typical for genes encoding ribosomal proteins, there are multiple processed pseudogenes of this gene dispersed through the genome. [provided by RefSeq, Jul 2008] |
RPLP0 Generibosomal protein, large, P0 Ribosomes, the organelles that catalyze protein synthesis, consist of a small 40S subunit and a large 60S subunit. Together these subunits are composed of 4 RNA species and approximately 80 structurally distinct proteins. This gene encodes a ribosomal protein that is a component of the 60S subunit. The protein, which is the functional equivalent of the E. coli L10 ribosomal protein, belongs to the L10P family of ribosomal proteins. It is a neutral phosphoprotein with a C-terminal end that is nearly identical to the C-terminal ends of the acidic ribosomal phosphoproteins P1 and P2. The P0 protein can interact with P1 and P2 to form a pentameric complex consisting of P1 and P2 dimers, and a P0 monomer. The protein is located in the cytoplasm. Transcript variants derived from alternative splicing exist; they encode the same protein. As is typical for genes encoding ribosomal proteins, there are multiple processed pseudogenes of this gene dispersed through the genome. [provided by RefSeq, Jul 2008] |
MALSU1 Genemitochondrial assembly of ribosomal large subunit 1 Enables mitochondrial large ribosomal subunit binding activity. Involved in negative regulation of mitochondrial translation and ribosomal large subunit biogenesis. Located in cytosol and mitochondrion. [provided by Alliance of Genome Resources, Mar 2025] |
DLGAP5P1 Genediscs, large (Drosophila) homolog-associated protein 5 pseudogene 1 |
LSG1 Genelarge 60S subunit nuclear export GTPase 1 This gene encodes a protein related to the yeast large subunit GTPase 1. The encoded protein is necessary for cell viability and may localize in the endoplasmic reticulum, nucleus and cytoplasm.[provided by RefSeq, Feb 2009] |
GVINP1 GeneGTPase, very large interferon inducible pseudogene 1 Predicted to enable GTP binding activity. Predicted to be located in cytosol and nucleus. [provided by Alliance of Genome Resources, Mar 2025] |
GVINP2 GeneGTPase, very large interferon inducible pseudogene 2 |
RPLP2P3 Generibosomal protein, large, P2 pseudogene 3 |
RPLP2P1 Generibosomal protein, large P2, pseudogene 1 |
RPLP2P5 Generibosomal protein, large, P2 pseudogene 5 |
RPLP2P4 Generibosomal protein, large, P2 pseudogene 4 |
CAPN2 Genecalpain 2, (m/II) large subunit The calpains, calcium-activated neutral proteases, are nonlysosomal, intracellular cysteine proteases. The mammalian calpains include ubiquitous, stomach-specific, and muscle-specific proteins. The ubiquitous enzymes consist of heterodimers with distinct large, catalytic subunits associated with a common small, regulatory subunit. This gene encodes the large subunit of the ubiquitous enzyme, calpain 2. Multiple heterogeneous transcriptional start sites in the 5' UTR have been reported. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2009] |
CAPN1 Genecalpain 1, (mu/I) large subunit The calpains, calcium-activated neutral proteases, are nonlysosomal, intracellular cysteine proteases. The mammalian calpains include ubiquitous, stomach-specific, and muscle-specific proteins. The ubiquitous enzymes consist of heterodimers with distinct large, catalytic subunits associated with a common small, regulatory subunit. This gene encodes the large subunit of the ubiquitous enzyme, calpain 1. Several transcript variants encoding two different isoforms have been found for this gene. [provided by RefSeq, Nov 2010] |
RPLP1P2 Generibosomal protein, large, P1 pseudogene 2 |
RPLP1P6 Generibosomal protein, large, P1 pseudogene 6 |
LARGE2 GeneLARGE xylosyl- and glucuronyltransferase 2 Predicted to enable dystroglycan binding activity; glucuronosyltransferase activity; and xylosyltransferase activity. Involved in protein O-linked mannosylation. Predicted to be located in intracellular membrane-bounded organelle. Predicted to be active in Golgi apparatus. [provided by Alliance of Genome Resources, Mar 2025] |
LARGE1 GeneLARGE xylosyl- and glucuronyltransferase 1 This gene encodes a member of the N-acetylglucosaminyltransferase gene family. It encodes a glycosyltransferase which participates in glycosylation of alpha-dystroglycan, and may carry out the synthesis of glycoprotein and glycosphingolipid sugar chains. It may also be involved in the addition of a repeated disaccharide unit. The protein encoded by this gene is the glycotransferase that adds the final xylose and glucuronic acid to alpha-dystroglycan and thereby allows alpha-dystroglycan to bind ligands including laminin 211 and neurexin. Mutations in this gene cause several forms of congenital muscular dystrophy characterized by cognitive disability and abnormal glycosylation of alpha-dystroglycan. Alternative splicing of this gene results in multiple transcript variants that encode the same protein. [provided by RefSeq, May 2018] |
RDPA Generefsum disease, adult, with increased pipecolicacidemia |
NPC2 GeneNiemann-Pick disease, type C2 This gene encodes a protein containing a lipid recognition domain. The encoded protein may function in regulating the transport of cholesterol through the late endosomal/lysosomal system. Mutations in this gene have been associated with Niemann-Pick disease, type C2 and frontal lobe atrophy. [provided by RefSeq, Jul 2008] |
NPC1 GeneNiemann-Pick disease, type C1 This gene encodes a large protein that resides in the limiting membrane of endosomes and lysosomes and mediates intracellular cholesterol trafficking via binding of cholesterol to its N-terminal domain. It is predicted to have a cytoplasmic C-terminus, 13 transmembrane domains, and 3 large loops in the lumen of the endosome - the last loop being at the N-terminus. This protein transports low-density lipoproteins to late endosomal/lysosomal compartments where they are hydrolized and released as free cholesterol. Defects in this gene cause Niemann-Pick type C disease, a rare autosomal recessive neurodegenerative disorder characterized by over accumulation of cholesterol and glycosphingolipids in late endosomal/lysosomal compartments.[provided by RefSeq, Aug 2009] |
CMT2H GeneCharcot-Marie-Tooth disease, axonal, type 2H |
CMT2G GeneCharcot-Marie-Tooth disease, axonal, type 2G |
GRD2 GeneGraves disease, susceptibility to, 2 |
GRD1 GeneGraves disease, susceptiblity to, 1 |
GRDX GeneGraves disease, susceptibility to, X-linked |
COPD14 GeneChronic obstructive pulmonary disease QTL 14 |
PDDC1 GeneParkinson disease 7 domain containing 1 Predicted to enable glyoxalase III activity. Predicted to be involved in methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione. Located in extracellular exosome. [provided by Alliance of Genome Resources, Mar 2025] |
CELIAC8 GeneCeliac disease, susceptibility to, 8 |
CELIAC2 Geneceliac disease 2 |
CELIAC5 GeneCeliac disease, susceptibility to, 5 |
CELIAC6 GeneCeliac disease, susceptibility to, 6 |
CELIAC7 GeneCeliac disease, susceptibility to, 7 |
AIS4 Geneautoimmune disease, susceptibility to, 4 |
COPD3 GeneChronic obstructive pulmonary disease QTL 3 |
COPD2 GeneChronic obstructive pulmonary disease QTL 2 |
COPD1 GeneChronic obstructive pulmonary disease QTL 1 |
COPD6 GeneChronic obstructive pulmonary disease QTL 6 |
COPD5 GeneChronic obstructive pulmonary disease QTL 5 |
COPD4 GeneChronic obstructive pulmonary disease QTL 4 |
COPD8 GeneChronic obstructive pulmonary disease QTL 8 |
PKHD1L1 Genepolycystic kidney and hepatic disease 1 (autosomal recessive)-like 1 Predicted to enable signaling receptor activity. Predicted to be involved in immune response. Predicted to act upstream of or within sensory perception of sound. Predicted to be located in cytosol; extracellular space; and membrane. Implicated in autosomal recessive nonsyndromic deafness. [provided by Alliance of Genome Resources, Mar 2025] |
BED GeneBornholm eye disease |
PKD1P1 Genepolycystic kidney disease 1 (autosomal dominant) pseudogene 1 |
PKD1P2 Genepolycystic kidney disease 1 (autosomal dominant) pseudogene 2 |
PKD1P3 Genepolycystic kidney disease 1 (autosomal dominant) pseudogene 3 |
PKD1P4 Genepolycystic kidney disease 1 (autosomal dominant) pseudogene 4 |
PKD1P5 Genepolycystic kidney disease 1 (autosomal dominant) pseudogene 5 |
PKD1P6 Genepolycystic kidney disease 1 (autosomal dominant) pseudogene 6 |
PKD3 Genepolycystic kidney disease 3 (autosomal dominant) |
PKD2 Genepolycystic kidney disease 2 (autosomal dominant) This gene encodes a member of the polycystin protein family. The encoded protein is a multi-pass membrane protein that functions as a calcium permeable cation channel, and is involved in calcium transport and calcium signaling in renal epithelial cells. This protein interacts with polycystin 1, and they may be partners in a common signaling cascade involved in tubular morphogenesis. Mutations in this gene are associated with autosomal dominant polycystic kidney disease type 2. [provided by RefSeq, Mar 2011] |
PKD1 Genepolycystic kidney disease 1 (autosomal dominant) This gene encodes a member of the polycystin protein family. The encoded glycoprotein contains a large N-terminal extracellular region, multiple transmembrane domains and a cytoplasmic C-tail. It is an integral membrane protein that functions as a regulator of calcium permeable cation channels and intracellular calcium homoeostasis. It is also involved in cell-cell/matrix interactions and may modulate G-protein-coupled signal-transduction pathways. It plays a role in renal tubular development, and mutations in this gene cause autosomal dominant polycystic kidney disease type 1 (ADPKD1). ADPKD1 is characterized by the growth of fluid-filled cysts that replace normal renal tissue and result in end-stage renal failure. Splice variants encoding different isoforms have been noted for this gene. Also, six pseudogenes, closely linked in a known duplicated region on chromosome 16p, have been described. [provided by RefSeq, Oct 2008] |
OED GeneOregon eye disease |
CHDS4 GeneCoronary heart disease, susceptibility to, 4 |
GBD3 Genegallbladder disease 3 |
CMTDIA GeneCharcot-Marie-Tooth disease, dominant intermediate 2 |
PDB6 GenePaget disease of bone 6 |
PDB4 GenePaget disease of bone 4 |
PDB5 GenePaget disease of bone 5 |
PDB1 GenePaget disease of bone 1 |
IBD9 Geneinflammatory bowel disease 9 |
IBD8 Geneinflammatory bowel disease 8 |
IBD3 Geneinflammatory bowel disease 3 |
IBD2 Geneinflammatory bowel disease 2 |
IBD5 Geneinflammatory bowel disease 5 |
IBD4 Geneinflammatory bowel disease 4 |
IBD7 Geneinflammatory bowel disease 7 |
IBD6 Geneinflammatory bowel disease 6 |
COPD17 GeneChronic obstructive pulmonary disease QTL 17 |
GBD2 Genegallbladder disease 2 |
PAOD1 GenePeripheral arterial occlusive disease 1 |
COPD7 GeneChronic obstructive pulmonary disease QTL 7 |
COPD9 GeneChronic obstructive pulmonary disease QTL 9 |
DDD3 GeneDowling-Degos disease 3 |
NAFLD2 GeneFatty liver disease, nonalcoholic, susceptibility to, 2 |
NAFLD1 GeneFatty liver disease 1, susceptiblity to |
EPM2A Geneepilepsy, progressive myoclonus type 2A, Lafora disease (laforin) This gene encodes a dual-specificity phosphatase and may be involved in the regulation of glycogen metabolism. The protein acts on complex carbohydrates to prevent glycogen hyperphosphorylation, thus avoiding the formation of insoluble aggregates. Loss-of-function mutations in this gene have been associated with Lafora disease, a rare, adult-onset recessive neurodegenerative disease, which results in myoclonus epilepsy and usually results in death several years after the onset of symptoms. The disease is characterized by the accumulation of insoluble particles called Lafora bodies, which are derived from glycogen. [provided by RefSeq, Jan 2018] |
PKDTS Genepolycystic kidney disease, infantile severe, with tuberous sclerosis |
AITD2 GeneAutoimmune thyroid disease, susceptibility to, 2 |
AITD1 GeneAutoimmune thyroid disease, susceptibility to, 1 |
AITD4 GeneAutoimmune thyroid disease, susceptibility to, 4 |
KWE Genekeratolytic winter erythema (Oudtshoorn skin disease) |
LOC613206 Genemyeloproliferative disease associated tumor antigen 5 |
RMD1 Generippling muscle disease 1 |
AD10 GeneAlzheimer disease-10 |
AD11 GeneAlzheimer disease-11 |
AD12 GeneAlzheimer disease 12 |
AD13 GeneAlzheimer disease-13 |
AD14 GeneAlzheimer disease 14 |
AD16 GeneAlzheimer disease 16 |
AD17 GeneAlzheimer disease 17 |
PKD1L1 Genepolycystic kidney disease 1 like 1 This gene encodes a member of the polycystin protein family containing 11 transmembrane domains, a receptor for egg jelly (REJ) domain, and a polycystin-1, lipoxygenase, alpha-toxin (PLAT) domain. The encoded protein may play a role in the male reproductive system. Alternative splice variants have been described but their biological nature has not been determined. [provided by RefSeq, Jul 2008] |
PKD1L2 Genepolycystic kidney disease 1-like 2 (gene/pseudogene) This gene encodes a member of the polycystin protein family. This protein may function as a G-protein-coupled component or regulator of cation channel pores. The long isoform of this protein contains 11 transmembrane domains, a latrophilin/CL-1-like GPCR proteolytic site (GPS) domain, and a polycystin-1, lipoxygenase, alpha-toxin (PLAT) domain. Alternative splicing results in multiple transcript variants encoding distinct isoforms. This gene is a polymorphic pseudogene in humans. [provided by RefSeq, May 2022] |
PKD1L3 Genepolycystic kidney disease 1-like 3 This gene encodes a member of the polycystin protein family. The encoded protein contains 11 transmembrane domains, a latrophilin/CL-1-like GPCR proteolytic site (GPS) domain, and a polycystin-1, lipoxygenase, alpha-toxin (PLAT) domain. This protein may function as a component of cation channel pores.[provided by RefSeq, Apr 2009] |
HDPA GeneHodgkin disease, susceptibility, pseudoautosomal |
AD6 GeneAlzheimer disease 6 |
AD7 GeneAlzheimer disease 7 |
AD5 GeneAlzheimer disease 5 |
AD8 GeneAlzheimer disease 8 |
AD9 GeneAlzheimer disease 9 |
PARK16 GeneParkinson disease 16 (susceptibility) |
PARK10 GeneParkinson disease 10 (susceptibility) |
PARK12 GeneParkinson disease 12 (susceptibility) |
HSCR9 GeneHirschsprung disease, susceptibility to, 9 |
HSCR8 GeneHirschsprung disease modifier 2 |
HSCR5 GeneHirschsprung disease, susceptibility to, 5 The disorder described by Hirschsprung (1888) and known as Hirschsprung disease or aganglionic megacolon is characterized by congenital absence of intrinsic ganglion cells in the myenteric (Auerbach) and submucosal (Meissner) plexuses of the gastrointestinal tract. Patients are diagnosed with the short-segment form (S-HSCR, approximately 80% of cases) when the aganglionic segment does not extend beyond the upper sigmoid, and with the long-segment form (L-HSCR) when aganglionosis extends proximal to the sigmoid. Total colonic aganglionosis and total intestinal HSCR also occur (Amiel et al., 2008 [PubMed 17965226]). Isolated HSCR appears to be of complex nonmendelian inheritance with low sex-dependent penetrance and variable expression according to the length of the aganglionic segment, suggestive of the involvement of one or more genes with low penetrance (Amiel et al., 2008 [PubMed 17965226]). For a general description and a discussion of genetic heterogeneity of Hirschsprung disease (HSCR), see MIM 142623.[supplied by OMIM, Feb 2011] |
HSCR7 GeneHirschsprung disease, short-segment, 3 |
HSCR6 GeneHirschsprung disease, short-segment, 2 |
IBD27 GeneInflammatory bowel disease-27 |
IBD20 GeneInflammatory bowel disease-20 |
IBD21 GeneInflammatory bowel disease-21 |
IBD22 GeneInflammatory bowel disease-22 |
IBD23 GeneInflammatory bowel disease-23 |
IBD24 GeneInflammatory bowel disease-24 |
IBD25 GeneInflammatory bowel disease-25 |
IBD26 GeneInflammatory bowel disease-26 |
CCAL1 Genechondrocalcinosis 1 (calcium pyrophosphate-deposition disease, early onset osteoarthritis) |
PARK3 GeneParkinson disease 3 (autosomal dominant, Lewy body) |
CELIAC9 GeneCeliac disease, susceptibility to, 9 |
CTD GeneCoats disease |
AD15 GeneAlzheimer disease-15 |
COPD13 GeneChronic obstructive pulmonary disease QTL 13 |
COPD12 GeneChronic obstructive pulmonary disease QTL 12 |
COPD11 GeneChronic obstructive pulmonary disease QTL 11 |
COPD10 GeneChronic obstructive pulmonary disease QTL 10 |
COPD16 GeneChronic obstructive pulmonary disease QTL 16 |
COPD15 GeneChronic obstructive pulmonary disease QTL 15 |
COPD19 GeneChronic obstructive pulmonary disease QTL 19 |
COPD18 GeneChronic obstructive pulmonary disease QTL 18 |
MYMY1 Genemoyamoya disease 1 |
MYMY3 Genemoyamoya disease 3 |
MYMY4 GeneMoyamoya disease 4 |
COPD GenePulmonary disease, chronic obstructive, severe early-onset |
CHDS3 GeneCoronary heart disease, susceptibility to, 3 |
CHDS2 GeneCoronary heart disease, susceptibility to, 2 |
CHDS1 GeneCoronary heart disease, susceptibility to, 1 |
CHDS9 GeneCoronary heart disease, suscpetibility to, 9 |
CHDS8 GeneCoronary heart disease, susceptibility to, 8 |
IBD11 GeneInflammatory bowel disease 11 |
IBD12 GeneInflammatory bowel disease 12 |
IBD15 GeneInflammatory bowel disease-15 |
IBD16 GeneInflammatory bowel disease-16 |
IBD19 GeneInflammatory bowel disease 19 |
IBD18 GeneInflammatory bowel disease-18 |
NDP GeneNorrie disease (pseudoglioma) This gene encodes a secreted protein with a cystein-knot motif that activates the Wnt/beta-catenin pathway. The protein forms disulfide-linked oligomers in the extracellular matrix. Mutations in this gene result in Norrie disease and X-linked exudative vitreoretinopathy. [provided by RefSeq, Feb 2009] |
PKHD1 Genepolycystic kidney and hepatic disease 1 (autosomal recessive) The protein encoded by this gene is predicted to have a single transmembrane (TM)-spanning domain and multiple copies of an immunoglobulin-like plexin-transcription-factor domain. Alternative splicing results in two transcript variants encoding different isoforms. Other alternatively spliced transcripts have been described, but the full length sequences have not been determined. Several of these transcripts are predicted to encode truncated products which lack the TM and may be secreted. Mutations in this gene cause autosomal recessive polycystic kidney disease, also known as polycystic kidney and hepatic disease-1. [provided by RefSeq, Jul 2008] |
PKD2L2 Genepolycystic kidney disease 2-like 2 Predicted to enable calcium channel activity. Predicted to be involved in detection of mechanical stimulus. Predicted to be active in membrane. [provided by Alliance of Genome Resources, Mar 2025] |
PKD2L1 Genepolycystic kidney disease 2-like 1 This gene encodes a member of the polycystin protein family. The encoded protein contains multiple transmembrane domains, and cytoplasmic N- and C-termini. The protein may be an integral membrane protein involved in cell-cell/matrix interactions. This protein functions as a calcium-regulated nonselective cation channel. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2011] |
COPD28 GeneChronic obstructive pulmonary disease QTL 28 |
COPD29 GeneChronic obstructive pulmonary disease QTL 29 |
COPD22 GeneChronic obstructive pulmonary disease QTL 22 |
COPD23 GeneChronic obstructive pulmonary disease QTL 23 |
COPD20 GeneChronic obstructive pulmonary disease QTL 20 |
COPD21 GeneChronic obstructive pulmonary disease QTL 21 |
COPD26 GeneChronic obstructive pulmonary disease QTL 26 |
COPD27 GeneChronic obstructive pulmonary disease QTL 27 |
COPD24 GeneChronic obstructive pulmonary disease QTL 24 |
COPD25 GeneChronic obstructive pulmonary disease QTL 25 |
CELIAC12 GeneCeliac disease, susceptibility to, 12 |
CELIAC13 GeneCeliac disease, susceptibility to, 13 |
CELIAC10 GeneCeliac disease, susceptibility to, 10 |
CELIAC11 GeneCeliac disease, susceptibility to, 11 |